More than a year after the public consultation closed, EMA and the Commission have announced moves that aim to clear the regulatory logjam holding back commercialisation of therapies based on tissues, cells and genes
The apps will improve self-care, adherence to therapy and long-term outcomes in this common, chronic condition, its developers say. The app for healthcare professionals will be one of the first such m-health apps to be CE-approved
Developing new antibiotics, from the first idea to proof of concept. The German-Australian iCAIR project brings together researchers from Fraunhofer ITEM, the MHH in Hannover and Griffith University in Australia.
Public-private drug research programme has - as yet - only provided limited examples of how it is delivering on its goals, an independent evaluation concludes
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.